Quadrasol Data Sheet

Reduction of inflammation and relief of pain associated with musculo-skeletal disorders and soft tissue lesions (traumatic injuries and surgical trauma). In cases of anticipated surgical trauma, Quadrisol can be given prophylactically at least three hours prior to elective surgery.

Quadrisol is intended for twice daily administration. The advised dosage is an initial dose of 2 mg/kg (2 ml/100 kg) followed by a maintenance dose of 1 mg/kg (1 ml/100kg) given every 12 hours. Treatment can be continued for a maximum of 14 consecutive days. Body weight and dosage rate must be accurately determined to avoid overdosing. In case of prophylactic treatment, a maximum duration of treatment of seven consecutive days is sufficient.

The gel is administered orally by inserting the nozzle of the syringe through the interdental space and depositing the required amount of gel on the back of the tongue. Before administration, the syringe should be adjusted to the calculated dosage by setting the ring on the plunger.

It is advisable to administer the product before feeding.

Do not use in animals suffering from alimentary tract disorders, impaired heart, liver or kidney function.

Do not use in lactating animals. Do not use in foals under the age of six months. Quadrisol must not be given with other non-steroidal anti-inflammatory drugs (NSAID’s) or glucocorticosteroids.

Undesirable effects

Typical NSAID side effects include lesions and bleeding in the alimentary tract, diarrhoea, urticaria, lethargy and inappetence. If symptoms occur, treatment should be discontinued. Symptoms are reversible. Overdosing may lead to death of treated animals.

If you notice any other side effects, please inform your veterinary surgeon.

Warnings

The safety of the veterinary medicinal product has not been established during lactation. Quadrisol 100 mg/ml can be used during pregnancy.

Horses with oral lesions should be assessed clinically and a decision should be taken by the attending veterinary surgeon as to whether treatment should be continued. Horses with persistent signs of oral lesions should not be treated. Horses should be monitored for oral lesions during treatment.

Avoid use in any dehydrated, hypovolaemic or hypotensive animals as there may be potential risk of increased renal toxicity. Horses intended for racing and competition should be treated according to local requirements. Appropriate precautions must be taken for such horses to ensure compliance with competition regulations. In case of doubt, it is advisable to test the urine.

For animal treatment only. Keep out of the reach of children.

Withdrawal period

Meat and offal: 12 days

Store between 15°C and 25°C.

Shelf life after first opening of the product: two months.

Do not use after the expiry date stated on the label.

Unused product and containers should be disposed of in accordance with any guidance from an appropriate waste regulation authority, e.g. the local office of the Environment Agency or SEPA.